Join Artur Fedorowski, MD, PhD, as he describes cardiovascular dysautonomia in COVID-19 and the diagnostics behind detecting Long COVID or Post-acute Sequalae of COVID-19.
A world-wide spread of the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has triggered a pandemic and generated over 600 million reported cases around the globe. A substantial portion of patients who suffered Corona Virus Disease 2019 (COVID-19) have not recovered completely but continue to experience lingering symptoms for months to years. This novel clinical syndrome has been termed Long COVID or Post-acute Sequalae of COVID-19 (PASC).
Observational studies have indicated that in about one third of cases PASC can be associated with cardiovascular (CV) autonomic dysfunction including postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia, orthostatic hypotension, reflex syncope and microvascular dysfunction. The presence of CV autonomic dysfunction in PASC is important to detect since although frequently overlooked, it may be effectively treated in contrast to many other Long COVID-related symptoms.
This webinar will highlight CV dysautonomia as a specific sequalae of acute COVID-19 and will guide the audience in the diagnostic work-up of PASC patients with suspected cardiovascular complications.
Key Topics Include:
- Understanding of the longer term effects of SARS-CoV-2 infection in Long COVID
- An outline of how Long COVID is associated with cardiovascular autonomic dysfunction
- How Long COVID could be diagnosed through the presence of autonomic dysfunction
Senior Consultant & Associate Professor